Heart Test Laboratories (HSCS) to Release Quarterly Earnings on Thursday

Heart Test Laboratories (NASDAQ:HSCS) is projected to announce its earnings results before the market opens on Thursday, March 13th. Analysts expect the company to announce earnings of ($2.53) per share for the quarter.

Heart Test Laboratories (NASDAQ:HSCS) last issued its earnings results on Monday, December 16th. The company reported ($2.27) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.30) by $0.03. During the same period last year, the company earned ($15.92) earnings per share. On average, analysts expect Heart Test Laboratories to post $-10 EPS for the current fiscal year and $-9 EPS for the next fiscal year.

Heart Test Laboratories Stock Down 6.6 %

Shares of HSCS opened at $2.99 on Thursday. Heart Test Laboratories has a 52-week low of $2.36 and a 52-week high of $14.20. The company has a market capitalization of $2.93 million, a PE ratio of -0.38 and a beta of 2.88. The stock has a fifty day simple moving average of $3.56 and a two-hundred day simple moving average of $3.46. The company has a quick ratio of 1.52, a current ratio of 1.72 and a debt-to-equity ratio of 0.01.

Analysts Set New Price Targets

Separately, Maxim Group reaffirmed a “buy” rating and issued a $12.00 target price on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.